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Effects of PCB Exposure on Biochemical
and Hematological Findings in Capacitor
Workers
by Richard W. Lawton,* Marie R. Ross,t Joseph Feingoldt
and John F. Brown, Jr.*
Certain formeroperations incapacitormanufacturing resulted in extensive direct contact oftheworkers
with electrical grade polychlorinated biphenyls (PCBs). A study group of 194 such individuals, all exposed
to Aroclor 1016 and many previously exposed to Aroclors 1242 and/or 1254, was examined before (1976)
and after (1979) discontinuance of PCB use in the operations (1977). At the two examinations, the ap-
proximate geometric mean serum levels (in ppb) and 5 to 95% ranges were for lower PCBs (LPCB), 363
(57-2270) and 68 (12-392); and for higher PCBs (HPCB), 30 (6-142) and 19 (4-108), respectively.
The statistical associations among 42 measured clinical chemical and hematological parameters, five
different measures of PCB exposure, and seven confounding variables observed in the two examinations
were determined by three regression procedures. Similar regressions were performed with DDE, which
was present at background levels. The principal statistical findings were a depression in serum bilirubin
and elevations in serum GGTP and lymphocyte levels at the time of the first examination, and only an
elevation in monocytes at the second. Appraisal of the results suggested an induction of microsomal
enzymes which appeared to be subsiding after the cessation of direct exposure to PCBs. The statistical
association between serum levels of PCBs and lipids reported by others was confirmed, but shown to be
explained by the partitioning behavior of PCB in the body, rather than to changes in liver function. No
evidence for health impairment related to PCBs was found, despite the high serum levels of PCBs in the
study population.
Introduction
Concern over the human health effects of the poly-
chlorinated biphenyls (PCBs) arises because of the en-
vironmental persistence ofthese substances, which were
widelyused inthe U.S. fornearly 50 years (1929-1978).
Several hundred million pounds still remain in exis-
tence, eitherinelectricalequipment orinenvironmental
compartments such as landfills, spillage sites or aquatic
sediments (1), so that the potential for human exposure
continues.
The main growth of PCB usage occurred only after
early toxicological studies and extensive industrial ex-
perience indicated these materials to be of relatively
low toxicity (2-5). In the 1970s, however, PCBs were
linked to an outbreak of severe chloracnegic disease in
southwestern Japan in 1968. The outbreak was traced
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to the ingestion of rice oil (Yusho) that had been con-
taminated with thermally decomposed PCB. The toxic
agents responsible for "Yusho disease" were ultimately
identified as 2,3,4,7,8-pentachlorodibenzofuran and other
polychlorinated dibenzofurans (PCDFs) (6), which are
formed from PCBs only at very high temperatures (7).
Despite contrary evidence, concern has remained that
ordinary, unpyrolyzed PCBs, even at residual environ-
mental concentrations, might also produce some human
health effects.
In order to identify such effects, a number of epide-
miological investigations have been performed on oc-
cupationally (8-19) orenvironmentally (20-22) exposed
populations. All such studies have indicated PCB-re-
lated health effects in the human to be uncommon, and
the only reasonably consistent findings to be statistical
associations between the levels ofserum PCBs and those
of serum lipids, e.g., triglycerides and cholesterol
(13,15,21,22). These associations have been interpreted
as suggestive ofotherwise asymptomatic alterations in
liver function.
This interpretation did not recognize that in the bodyLAWTON ETAL.
PCBs are partitioned between adipose tissue (the major
reservoir) and blood serum in proportion to the lipid
content of the serum (23,24). Therefore, statistical as-
sociations of serum PCBs with serum lipids and any
covariant parameters could arise solely from such par-
titioning. In order to determine whether PCBs actually
do have any effect upon serum lipid levels, it would be
necessary to examine the dependence ofthe latter, not
upon the levels of PCB in the serum, but instead upon
their levels within the body lipids. Forlipid-soluble ma-
terials, the concentration within the body's lipid phases
haslongbeenrecognized asthedeterminantofthephar-
macological response (25).
In addition to the consistently observed association
between the levels of PCBs and lipids in the serum,
there have been isolated reports of hypertension (22),
hepatomegaly (14), chloracne (14,22), other dermal ef-
fects (12-14), oxidase induction (16), restrictive lung
disease (18), increased levels ofserum -y-glutamyl tran-
speptidase (14,15,22), serum glutamic oxalacetic trans-
aminase (13-15), serumglutamic pyruvic trans aminase
(12,14), serum ornithin-carbamoyl transferase (14), or
serum pseudocholine esterase (14), increased bromsul-
phthalein retention (12), or reduced plasma HDL cho-
lesterol (15) in the groups studied. Most such reports,
however, either lack consistency with the findings of
other investigators, or were observed only in groups
that were small, lightly exposed to PCBs, and/or ex-
posed to PCBs in combination with other chemicals.
An opportunity to study the effects of unpyrolyzed,
electricalgrade PCB exposure hasbeenprovided attwo
capacitor manufacturing plants located within a mile of
each other along the Hudson River in upstate New York.
During their period ofPCB use (1946-1977), these plants
are believed to have been the largest single U.S. users,
consumingabout 15% ofallU.S. production, andtohave
had one of the largest PCB-exposed work forces. Be-
tween 1946 and 1975, approximately 9500 different em-
ployees worked there, and the employment during the
1976-1979 period of this study was between 1500 and
1800.
Previous investigators of this plant population have
found its mortality experience (reported as that for
"Plant 2" by Brown and Jones) (19) to be normal for all
major causes of death, and have indicated a general
paucity ofsignificant clinical effects in a volunteer sam-
ple drawn from the plant population as a whole (17).
However, only 5 to 10% ofthe plant employees worked
in areas or jobs providing direct, continuing exposure
to the dielectric fluids. Thus, it appeared probable that
this exposed subpopulation, stillasizeable group, might
exhibitconsiderably greaterbloodPCB levelsandphys-
iological effects than the remainder of the plant
population.
Accordingly, a study population was selected, using
criteria that were broad enough to include the entire
directly exposed group, as well as some less directly
exposed individuals, and detailed clinical examinations
were performed approximately 16 months before and
29 months after the discontinuance of PCB use in the
plant. No attempt was made to establish a comparable
age-andsex-matched controlcohort, butsincethestudy
group itself exhibited a distribution ofPCB levels cov-
eringovertwo orders ofmagnitude, analyseswithinthe
group offered adequate prospects for identifying and
quantifying physiological effects attributable to the
PCBs.
Since it was not possible, initially, to decide which of
the many clinically measured varaiables might be af-
fected by PCBs or might confound the study, a three-
tiered analysis was used to identify statistically signif-
icant associations. In order, these analyses were: (a) a
simple linearregression, intrinsically bias-free, foreach
measured variable or its log transform against each
measure ofPCB exposure; (b) a multiple linear regres-
sion for each of the measured variables against the se-
lected measures ofPCB exposure and a series ofother
independent variables, e.g., sex, age, smoking history,
body mass index, etc., believed to have effects on one
or more of the clinical variables and (c) a backward
stepwise linear regression to remove non significant in-
dependent variables. For each regression, statistically
significant associations (p < 0.05) with the measures of
PCB were identified. In addition, the 95% confidence
limitsoftheregression coefficientwereusedtoestimate
the significance of the association over the observed
range ofexposure. Similar regressions were performed
for the same measures ofp,p'-DDE, which shares with
PCBs partitioning behavior in lipids.
Materials and Methods
Description of Environment
Intheprocessusedformanufacturingliquiddielectric
capacitors, metal foil strips separated by paper layers
werewoundintotightcoilsandinsertedintometalcans.
A cover assembly, having electrical connectors and a
port to admit the dielectric fluid, was then sealed to the
can. For filling, small capacitors, such as those used in
fluorescent light ballasts, were packed onto racks that
were placed in large autoclaves, warmed, degassed un-
der vacuum, and then flooded with the dielectric fluid.
Therackswerethendrained, removed, andtransported
to sealing stations where the port was manually sealed
with solder. Large power capacitors were originally filled
manually; subsequently, they were filled by an elec-
tronically controlled manifold system which reduced
spillage and dermal contact. Following sealing, bothlarge
and small capacitors were cleaned, degreased, tested,
repaired if appropriate, labeled, and packed for ship-
ment. The dielectric fluids were blended with stabiliz-
ers, treated with fuller's earth to remove polar
impurities, and tested for dielectric properties, thereby
producing an "electrical grade" product. Thejobs which
provided frequent or continuous direct exposure to the
dielectric fluids (i.e., direct dermal contact and/or close
proximity to a source of vapor) were those associated
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with the fluid processing, the handling and sealing of
wet capacitors, capacitor salvage and repair, and the
quality control laboratory.
Aroclor 1254, a commercial mixture of PCB isomers
and homologshavingthe averagemolecularcomposition
of a pentachlorobiphenyl, was used initially in the two
plants (1946 ff.). During 1953-1955 a transition was made
to Aroclor 1242, a PCB mixture having the average
composition ofatrichlorobiphenyl, for all but a few spe-
cialty capacitors. In 1971, all use of Aroclor 1254 was
phased out, and Aroclor 1242 was replaced by Aroclor
1016, a PCB mixture that also had the average compo-
sition ofa trichlorobiphenyl, but which had been redis-
tilled by the manufacturer to remove all homologs
containing more than four chlorines per biphenyl. Fi-
nally, on June 30, 1977, all PCB use ceased. The sta-
bilizer used with the Aroclor 1254 mixture was 1-
chloroanthraquinone; that most commonly used with
Aroclors 1242 and 1016was UnionCarbide epoxide 4221.
In late 1975, PCB area air levels (reported as Aroclor
1242) around the capacitor filling and sealing area were
found to be in the range 200 to 2000 ,ug/m (geometric
mean, 690 ,ug/m). Subsequent to the cessation of PCB
use they dropped steadily to a mean of16 p,g/m in April
1983. The TWA levels indicated by personal air sam-
plers on directly exposed personnel in these areas in
early 1977 were reported by Brown and Jones (19) to
average 168 ,ug/m (range, 24-393 ,ug/m), or about half
the mean area levels that we measured at that time.
These investigators also measured the levels of trich-
loroethylene (used indegreasing); tin, lead and zinc (sol-
dering operations); aluminum and iron (welding
operations); and toluene and methyl isobutyl ketone
(painting operations): all were generally within OSHA
standards.
Unfortunately, there are no data regarding PCB air
levels during the 1946-1974 period. Major changes in
plant ventilation and changes inthe Aroclors used made
it impossible to estimate those levels.
Study Population
The study population was selected in early 1976 to
include all those workers (a) whosejobs required direct
occupational contact with PCBs in high air level zones,
such as those in handling and sealing wet capacitors,
and capacitor salvage and repair; (b) whosejobs did not
involve direct PCB contact, but were at the periphery
ofthehigh exposure zone; and (c) whose dutiesrequired
brief high exposure and contact, such as maintenance
men. At the time of the 1976 examination, this study
population included 152 males and 42 females. Ofthese,
41 had service times beginning during the period when
the predominant dielectric fluid was Aroclor 1254, 103
began service when it was Aroclor 1242, and 50 had
been exposed only to Aroclor 1016. The mean service
times and ages in the study population were 17 years
(range, 2-35) and 40 years (range 20-65), respectively.
Thirty-three ofthe 194 were also members of the 326-
member volunteer group examined by Fischbein et al.
a little later in 1976 (17). By the time of our 1979 ex-
amination, our directly exposed study group was re-
duced to 174 workers due to relocation, although still
including 14 retired and/or relocated workers who re-
turned for the reexamination.
At the time of the initial population selection an es-
timate of the relative PCB exposure was made by one
ofus (M. R.) on the basis ofthe individual worker'sjob
activities. The estimated exposure categories (abbrevi
ated as EXE below) generally corresponded to those
used for selection, e.g., "low" for peripherally exposed
jobs; "medium" for those with intermittent exposure;
and "high" for those with continuous direct exposure.
After the serum PCB data became available, analysis
showed that the "low" and "medium" categories were
statistically indistinguishable in terms of serum PCB
means.
Clinical Measurements
The clinical examinations were conventional but rel-
ativelycomplete. Theyincluded amedicalhistory, phys-
ical examination by the plant physician (J.F.), ECG,
chest X-ray, spirometry, 26-parameter biochemical an-
alysis, hematology, and urinalysis. Body weight was
measured in light indoor clothing and height measured
without shoes. Systolic and diastolic blood pressure were
measured in the seated position to the nearest 5 mm.
The participants were instructed to be fasting for the
preceding 12-hr period with water ad libitum.
The decision to measure serum PCB levels in 1976
was made during the course of the study, so that only
41 workers had the blood samples required forthe PCB
analysis drawn while fasting; the remainder were re-
called and sampled in the nonfasting state. All of the
1979 measurements were made on fasting sera.
In 1979, the physical examination, ECG, and chest
X-ray were repeated only in special cases, but the med-
ical history was expanded and improved, particu larly
in relation to smokinghabits. Documentation on alcohol
consumption remained incomplete and generally
unreliable.
The chest X-rays were read by a local radiologist
(R. C. Batt) who coded the findings according to the
ILO/UC criteria (CRC/NIOSH (M) 2.8, Rev. 4/80).
ECG's were interpreted by one of us (J.F.). Clinical
chemical analyses were performed on the serum sam-
ples using an SMA-26, and hematological analyses on
EDTA venous blood specimens, by Medpath (Teter-
boro, N.J.). The total serum lipids were measured in
1976 by using the phenol turbidity method, but not in
1979; the method has been criticized (26) as unreliable
for total serum lipids. In 1979 serum triglycerides were
reported numerically up to 400 mg/dL and thereafter
as 8 400 mg/dL. WBC differentials were performed
manually in 1976 and with the Technicon Hemalog D in
1979. Serum osmolarity was calculated from the elec-
trolytes and crystalloids (BUN, blood glucose) by con-
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ventional procedures. The mean corpuscular hemoglobin
was calculated from the reported red blood cell count
and hemoglobin values in 1976.
Serum PCB and DDE Measurements
The PCB determinations uponboththe 1976and 1979
serum samples were performed by Hazelton Raltech
(Madison, WI) using conventional PCB extraction,
packedcolumngaschromatographic, anddatareporting
procedures, which are discussed in detail elsewhere (27).
These procedures also provided data on the levels of
DDE present. The observed distributions of PCB iso-
merpeaks inthe capacitor workers' chromatograms are
also described elsewhere (27); they differed markedly
fromthose inthe Aroclor 1016, 1242 and 1254 standards
because ofmetabolism andelimination ofallofthemono-
and dichlorobiphenyl isomers, most of the tri-and te-
trachlor, and many ofthe pentachloro isomers as well.
The serum PCB levels were reported by the analyst
in 1976 as levels ofAroclors 1242 and 1254, and in 1979
as Aroclors 1242, 1254, and 1260. These were calculated
from the observed chromatograms byratioingthe sums
of certain selected peak heights to those of the corre-
sponding peaks in Aroclor standards. The selected peaks
were, for Aroclor 1242, those having retention times
(relative to that for DDE, times 100) of 37, 70 and 84;
for Aroclor 1254, those at 125, 146, 160 and 186; for
Aroclor 1260, those at 125, 146, 160, 186, 197, 294 and
372. Because ofthe differences in PCB composition be-
tweentheserumsamplesandthestandards, suchvalues
overstate the amounts of PCB actually present. The
latter are now more commonly described in terms of
values for LPCB ("lowerPCBs," i.e., allisomers having
gas chromatographic retention times on silicone less than
that of DDE, which comes in the middle of the pen-
tachlorobiphenyl range), and HPCB ("higher PCBs,"
i.e., those with retention times > DDE) with the sum
ofLPCB and HPCB representingthetotalPCB present
(TPCB). We have shown elsewhere (27) that for our
more heavily exposed subjects the factorforconverting
a reported serum Aroclor 1242 value to LPCB is 0.237;
for Aroclor 1260 to HPCB, 0.71. The factor for con-
verting the 1976 Aroclor 1254 values to HPCB was es-
timated from the chromatograms as 0.35.
In 1980 it was found that the individual 1979 values
ofAroclor 1242, Aroclor 1254 and DDE, relative to the
population means, were highly correlated with the cor-
respondingvaluesin 1976, butthatthe 1979valueswere
generally several times higher, despite the limited ex-
posure to either PCB or DDE during the intervening
period, indicating that one ofthe data sets contained a
systematic error. Review ofthe methodology and tests
on control samples confirmed the validity of the 1979
procedure (27); however, the standardization error in
the 1976 data could not be identified after the 4-year
time lapse, and the analyst could not verify the 1976
serum PCB and DDE measurements. Accordingly, we
have reported here all such data as the originally re-
ported numerical quantity times a correction factor x.
Determination ofthe value of x was not required for
the statistical association studies, butwas forestimates
of actual PCB levels and clearance. To estimate x, we
usedtheDDE peakonthechromatogramsasaninternal
standard; there had been no more than background ex-
posure of the study group to this substance, which is
highly persistent in the body, during the 1976-1979 pe-
riod. The geometric mean DDE value for 1979 was cal-
culated directly from the reported data; that for 1976
using the maximum likelihood estimate for censored data
(28), since 87 of the 140 1976 values for p,p'-DDE had
been reported as
- 1 ppb. The resulting values (10.2
and 1.18 ppb, respectively) indicated the mean value of
x to be about 10, suggesting a possible decimal point
error in 1976.
Lipid PCB Determinations
Serumcholesterol lipids (free cholesterol plus cho les-
terol esters) were estimated from normal values (26) as
1.50timestheclinicallyreportedserumcholesterol(i.e.,
cholesterol equivalent) values. Total serum neutral lip-
ids were calculated as the sum ofthe clinically reported
serum triglycerides plus the serum cholesterol lipids.
Serum lipid PCBs were calculated as the gross serum
PCBs divided by serum neutral lipids. It is shown else-
where (23,24) that PCBs partition between serum and
adipose tissue fat in direct proportion to the content of
neutral lipids as specified by this procedure; thus, this
measure ofthe serum lipid PCB level is approximately
equal to the PCB level in adipose tissue fat. However,
the regression results were not particu larly sensitive
to the exact procedure used for calcu lating serum lipid
phases and comparable findings were obtained when
they were calculated instead as simply the sum of the
serum triglycerides and the serum cholesterol.
Statistical Analyses
Statistical analyses were performed on a Honeywell
600/6000 computer, using STATPAC (28), a versatile
general statisticalprogramwithmanyofthecapabilities
ofthe more widely used BMDP series (29), for the dis-
tribution plotting; simple, multiple and stepwise linear
regression; and maximum likelihood estimates for cen-
sored data.
To evaluate the distributions of the dependent vari-
ables, probability plots of both the measured and lo-
garithmatically transformed data were prepared and
compared for linearity. The choice for a number ofthe
distributions seemed equivocal, with the arithmetic and
geometric means approximately equal. We generally
selected the distributions yielding the highest F-ratios
in the regressions, or the distributions which tended to
produce normal residuals. Partial residual plots were
prepared and examined in cases where there was a sig-
nificant PCB association. Outliers were not removed.
The residuals from the regression appeared to be nor-
mally distributed with only a few exceptions (blood,
glucose, red cell indices), in which cases the distribu
tions were not improved by data transformation.
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The independent variables used in the multiple and
stepwise regressions, as identified from preliminary
studies, were as follows:
* Sex (SEX). Workers were coded as males = 1 and
females = 2 so that a positive association repre-
sented an attribute of females.
* Age (AGE). The numerical age to the nearest year
in 1976 was used. Service time and age covaried (r
= 0.75).
* Urinary Specific Gravity (SPG). A number of var-
iables appeared sensitive tothe degree ofhydration
inthesefastingsubjects, principallythecrystalloids
(blood glucose, blood urea nitrogen).
* Disease Status (DS). Thirteen workers were iden
tified as having significant conditions bearing upon
the analysis. Theyincluded diabetics (5), those with
alcohol problems (3), nonfasting at examination time
(3), one worker who was post-pituitary surgery,
and one worker with epilepsy taking Dilantin. A
dummy variable was created (disease absent = 0,
disease present = 1) to identify these cases.
* Nonfasting PCB Measurement (FNF). In the 1976
data individuals whose serum PCB levels were ob-
tained in the nonfasting state were coded as 0; fast-
ing measurements were coded as 1.
* Smoking (SC). Smokers and ex-smokers were coded
as 2, nonsmokers as 1.
* Job Status (JS). For the 1979 analysis, workers
continuing in employment were coded as 0, sepa-
rated or retired workers as 1.
* Body Mass Index (BMI). The body mass index (W/
H) was calculated for each individual in 1976 and
1979 and used as an independent variable.
In the stepwise regressions, the criterion for adding
an independent variable was an F value of3.0; that for
removing a variable was 4.0. The numbers of subjects
in the stepwise regressions were only 159-166, rather
than the 189-194 used in the simple regressions, be-
cause ofincomplete data. Inaddition, 41 cases had miss-
ing hematological data in 1976 (Table 1) yielding an N
of 128 for these analyses.
Because half of the 1976 gross serum DDE values
were reported only as
- lx ppb, a dummy variable (-
lx ppb = -1, > lx ppb = +1) was used in the regres-
sions, and no attempt was made to estimate serum lipid
DDE values. The 1979 gross serum DDE and serum
lipid DDE levels were expressed in the same terms as
the corresponding measures of PCB.
Results
Clinical Characteristics ofthe Study
Population
The medical history and physical examination ofthe
studypopulationrevealed avariety ofclinical conditions
and health-related practices.
Sixty-five percent ofthe population were smokers or
ex-smokers, and 26 workers (17%) showed obstructive
patterns on repeated spirometric testing. There were
six chest X-ray reports of possible emphysema.
Fiftypercent ofthe population was overweight [>1.2
times the "desirable" weight by 1959 standards (30)]
and many were frankly obese. Hypertension histories
were obtained on 11.3%. Elevated diastolic pressures
(>90 mm Hg) were found in 19.6% ofthe population at
examination in 1976 as compared to 14.7% at the time
of employment. Reported urinary tract problems in-
cluded renal stone or "gravel" in 8 subjects; surgically
corrected congenital obstruction in one; bladder, kid-
ney, or prostatic infection in 14; and one benign bladder
tumor.
Forty-fiveworkers showed one ormore elevated fast-
ing blood glucose values between 1976 and 1979. Of
these, 5 were known diabetics, 30 were found to give
normal postprandial values, and the remainder showed
normal fasting values when retested.
A review ofthe medical dispensary records ofall PCB-
exposed employees between 1960 and 1975 revealed 49
visits for contact dermatitis attributed to the dielectric
fluid. There were an additional 16 visits for nausea,
dizziness, oreye ornasalirritationfollowingshortinitial
exposure to the workplace. In all cases the conditions
subsided with removal from exposure. Chloracne was
never observed in the plant work force.
Clinical Laboratory Findings
The distributions ofclinical chemical and hematolog-
ical values observed in the study population are de-
scribed in Table 1, along with the normal ranges
unadjusted for sex and age, and asterisks indicating
variables having values outside these rough reference
ranges.
The numbers of individuals reported by the clinical
laboratory to be outside its internal age- and sex- ad-
justed standards (based on ± 2 standard deviations
from mean values) are listed for each reported param-
eter in Table 2. If the parameters were normal and
normallydistributed, onewouldexpectfourorfivecases
to fall along each tail of these distributions, making a
total of eight to ten.
Table 2 indicated substantial numbers of individuals
with elevations in serum triglycerides, cholesterol, and
SGPT in both 1976 and 1979, and in blood glucose and
albumin/globulin ratio in 1976. Some elevations in BUN
and chloride were found in 1979. In 1976 there were
some elevations in total WBCs associated with de-
creased PMNs and increased lymphocytes, monocytes,
and eosinophils. In 1979 there were marginal increases
in monocytes and eosinophils, but the WBCs were near
normal. Urinalysis in both 1976 and 1979 showed ele-
vated cell counts, but no attempt had been made to
obtain a clean catch. Urinary specific gravity and cal-
culated serum osmolarity were both elevated in 1976
and 1979 (Table 1).
Theobserved distributions ofserumtriglyceridesand
serumcholesterol are showningreaterdetailin Figures
1 and 2. The cross-hatched bars represent values that
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Clinical
measurementsa
Table 1. Distribution of clinical laboratory finding in study population of PCB-exposed capacitor workers.
1976 (N = 194) 1979 (N = 174)
Std. AM or Percentiles Missing AM or Percentiles Missing
Units Dist. rangeb Mean ± SD GM 5th 95th values Mean ± SD GM 5th 95th values
Serum triglycerides
Serum total cholesterol
Serum neutral lipidsc
SGOT
SGPT
SGGTP
Serum alkaline phosphatase
Serum lactic dehydrogenase
Serum total protein
Serum albumnin
Serum globulin
Albuming/globulin ratio
Blood urea nitrogen
Serum creatinine
Bun/creatinine ratio
Serum total bilirubin
Serum direct bilirubin
Blood glucose
Serum uric acid
Serum Na
Serum K
Serum Ca
Serum Mg
Serum Cl
Serum P
Serum osmolarity
Specific gravity (urine)
Serum iron
RBC
HG
HCT
MCV
MCHc
MCHC
WBC
PMNS
# PMNS
Lymphocytes
% Lymphocytes
Monocytes
% Monocytes
Eosinphils
% Eosinphils
Basophils
% Basophils
mg/dL LN 50-200
mg/dL N 125-300
mg/dL N
IU/L LN 1-50
IU/L LN 1-55
U/L LN 1-70
IU/L LN 15-55
IU/L N 97-250
g/dL LN 6.2-8.3
g/dL LN 3.8-5.1
g/dL N 2.1-4.0
LN 1.2-2
mg/dL LN 7-28
mg/dL N 0.8-1.8
LN
mg/dL LN 0.1-1.4
md/dL N 0-0.4
mg/dL LN 65-130
mg/dL N 3.3-8.9
mmole/L N 134-146
mmole/L N 3.4-5.4
2.133 0.224 135.8 58.9 310*
251.3 55.2 251.3 159.2 342.5*
2.709 0.127 512.1 316 829
1.374 0.152 13.3 23.7 41.9
1.460 0.189 28.9 14.1 58.8*
1.091 0.266 12.3 4.50 33.8
1.419 0.142 26.2 15.8 43.4
160.1 28.2 160.1 114.5 205.4
0.858 0.079 7.21 6.45 8.04
0.648 0.032 4.44 3.92 5.02
2.77 0.51 2.77 1.93 3.60
0.213 0.099 1.63 1.12 2.38*
1.185 0.119 15.3 9.72 24.0
1.30 0.21 1.30 0.95 1.64
1.078 0.124 12.0 7.45 19.10
-0.339 0.193 0.46 0.22 0.95
0.15 0.08 0.15 0.02 0.27
2.010 0.057 102.4 82.8 126.5
5.74 1.25 5.74 3.65 7.80
139.5 2.67 139.5 135.1 143.9
4.26 0.44 4.26 3.54 4.98
mg/dL N 8.7-10.5 9.87 0.49 9.87 9.06 10.7*
meq/L N 1.6-2.3
mmole/L N 96-109 102.0 2.93 102.0 97.1 106.8
mg/dL N 1.9-4.3 3.01 0.44 3.01 2.28 3.74
mosm/kg N 280-295 299.0 6.06 299.0 288.9 309.0*
g/cm3 N 1.026 0.005 1.026 1.017 1.035*
,ug/dL N 55-200 112.1 36.1 112.1 53.1* 170.6
106/mm3 N 4.3-6.4 4.94 0.42 4.94 4.24* 5.63
g/dL N 13.0-18.5 14.8 1.67 14.8 12.5* 17.0
% N 39.5-57.0
p.3 N 80-103
,.pg N 26-33 30.0 1.89 30.0 26.9 33.1
% N 30.6-36.0
103/mm3 N 4.1-11.9 7.02 1.74 7.02 4.21 9.81
103/mm3 N 1.65-8.33 4.20 1.32 4.20 2.02 6.37
% WBC N 45-77 59.7 9.57 59.7 44.3 74.9
103/mm3 N 1.05-3.58 2.33 0.76 2.33 1.07 3.57
% WBC N 16-45 33.8 9.64 33.8 18.2 49.2*
103/mm3 N 0.06-0.93 0.30 0.17 0.30 0.02 0.59
% WBC N 0-8 4.38 2.14 4.38 0.87 7.95
103/mm' N 0.04-0.42 0.13 0.13 0.13 0 0.32
% WBC N 0-4 1.84 1.73 1.84 0 4.34*
103/mm3 N 0.01-0.15
% WBC N 0-2
1 2.157 0.225 143.7 61.3 336.9*
1 238.1 50.1 238.1 155.7 320.4*
1 2.702 0.119 503.3 321 789
1.448 0.144 28.0 16.3 48.4
1 1.537 0.164 34.4 18.5 63*
2 1.198 0.263 15.8 5.82 42.7
1.465 0.122 29.1 18.4 46.3
173.6 31.3 173.6 122.1 225.1
0.864 0.028 7.30 6.58 8.11
1 0.644 0.036 4.41 3.84 5.05
3 2.92 0.43 2.92 2.21 3.63
3 0.182 0.082 1.52 1.11 2.07
1 1.227 0.115 16.9 10.9 26.0
1 1.32 0.20 1.32 0.99 1.65
2 1.112 0.127 12.0 8.00 20.9
-0.218 0.168 0.61 0.32 1.14
1 0.14 0.07 0.14 0.02 0.26
1 1.995 0.056 98.8 79.8 122.3
1 6.01 1.30 6.01 3.88 8.15
2 139.4 2.32 139.4 135.6 143.2
2 4.42 0.46 4.42 3.66 5.17
1 9.67 0.42 9.67 8.97 10.4
1.91 0.15 1.91 1.66 2.15
2 103.8 3.27 103.8 98.4 109.1*
1 2.85 0.44 2.85 2.12 3.58
2 299.5 5.37 299.5 290.6 304.3*
5 1.026 0.005 1.026 1.018 1.03*
2 108.2 29.1 108.2 60.3 156.2
1 5.05 0.39 5.05 4.39 5.70
1 15.4 1.18 15.4 13.4 17.4
46.2 3.55 46.2 40.3 52.1
91.6 5.18 91.6 83.1 100.0
1 30.6 1.61 30.6 27.9 33.1
33.5 2.05 33.5 31.2 35.7
2 6.90 1.87 6.90 3.85 9.92
41 4.12 1.46 4.12 1.77 6.45
41 59.0 8.65 59.0 44.6 73.2
41 2.09 0.64 2.09 1.03 3.14
41 30.9 7.84 30.9 17.9 43.9
41 0.48 0.22 0.48 0.12 0.83
41 6.90 2.57 6.90 2.60 11.2*
41 0.16 0.12 0.16 0 0.33
41 2.34 1.78 2.34 0 4.8*
0.046 0.026 0.046 0.003 0.090
0.68 0.38 0.68 0 1.30
a All blood chemical determinations made on serum: hematology measurements in EDTA venous blood. Abbreviations: SGOT, serum glutamic-oxalacetic
transaminase; SGOT, serumglutamic-pyruvic transaminase;SGGTP, serumyglutamyltranspeptidase; LDH, serumlacticdehydrogenase; A/GRatio, albumin/globulin
ratio; BUN, blood urea nitrogen; RBC, red blood cell count; HG, hemoglobin; HCT, hematocrit; MCV, mean red cell corpuscular volume; MCH, mean red cell
corpuscular hemoglobin; MCHC, mean red cell corpuscular hemoglobin concentration; WBC, white blood cell count; PMN, polymorphonuclear white cells.
blaboratory standard ranges unadjusted for sex and age. Asterisk (*) indicates values outside these ranges. Arithmetic (AM) orgeometric (GM) meansgiven based
on selected distribution (N = normal, LN = lognorrnal).
fell outside the 95th percentile for age from the Lipid
Research Clinics Prevalence Study (31). By the LRCP
study criteria, the portions of the male population ex-
hibitingelevations intriglycerides in 1976and 1979 were
5.7% and 12.6%, respectively. This elevation was sig-
nificant at the 1% level by paired t-test. For females,
the elevation in triglycerides was significant at the 5%
level but was found inthe younger women and appeared
to be related in partto obesity and estrogen medication.
Of unknown significance were the differences in ana-
lytical methodology (fluorimetric method with Techni-
con Autoanalyser used by LRCPS; enzymatic method
with discrete analyser used here). The serum choles-
terol values (Fig. 2) were normally distributed. By the
LRCPS criteria, the portions ofthe entire group above
the 95th percentile in cholesterol in 1976 and 1979 were
29.4% and 23.3%, respectively.
Measures of PCB Exposure
Table 3 shows the means and ranges for serum PCB
concentrations described in four ways: first as the Ar-
2
2
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Table 2. Numbers of study group members reported by clinical laboratory to have clinical variables outside normal (95%) age- and
sex-adjusted ranges.
1976 (N = 194) 1979 (N = 174)
Clinical variablesa Males Females Tbtal +/_ Splitb Males Females Tbtal +/-Splitb
Trigylcerides 36 4 40 *38/2 38 3 41 *41/0
Total cholesterol 27 7 34 *33/1 20 3 23 *22/1
SGPT 15 0 15 *15/0 12 1 13 *13/0
SGOT 6 1 7 *7/0 3 0 3 3/0
GGTP 6 0 6 *6/0 3 0 3 3/0
Alkaline phosphatase 1 1 2 2/0 5 2 7 4/3
LDH 3 0 3 3/0 2 1 3 3/0
Blood glucose 25 4 29 *29/0 3 3 6 *6/0
Uric acid 2 1 3 2/1 3 0 3 3/0
TItal bilirubin 0 0 0 0/0 2 2 4 4/0
Direct bilurubin 1 0 1 1/0 1 1 2 2/0
Ibtal protein 4 0 4 4/0 2 2 4 3/1
Albumin 0 0 0 0/0 8 2 10 1/9*
Globulin 9 3 12 7/7 1 2 3 2/1
A/G ratio 12 2 14 *13/1 6 2 8 4/4
BUN 4 2 6 *6/0 6 3 9 *9/0
Creatinine 1 0 1 1/0 1 0 1 1/0
Na 3 2 5 4/1 2 0 2 0/2
K 3 0 3 1/2 5 1 6 5/1
Cl 1 0 1 0/1 9 4 13 *11/2
Ca 1 1 2 0/2 3 2 5 3/2
P 0 0 0 0/0 1 0 1 0/1
Mg 1 0 1 0/1
Iron 5 1 6 5/1 6 0 6 2/4
RBC 2 1 3 1/2 1 0 1 0/1
Hemoglobin 3 0 3 3/0 2 0 2 1/1
Hematocrit 1 0 1 1/0 4 0 4 5/1
MCV 4 0 4 3/1
MCH 10 1 11 *8/3
MCHC 1 0 1 0/1
WBC 11 2 13 9/4 8 3 11 7/4
Differential
PMNs 7 4 11 2/9* 1 0 1 1/0
Lymphocytes 8 5 13 *11/2 8 2 10 5/5
Monocytes 7 2 9 *9/0 3 3 6 *6/0
Eosinophils 6 1 7 *7/0 4 2 6 *6/0
Basophils
Urinalysis
Albumin 3 2 5 5/0 0 1 1 1/0
Acetone 1 1 2 2/0 2 1 3 3/0
Cells 12 12 24 *24/0 4 8 12 *12/0
aSee Table 1 for abbreviations used.
bAsterisk (*) indicates significant probability (95%) of increase or decrease assuming a true binomial proportion of 0.5.
oclorlevelsreported bythe analyticallaboratory, based
on measurements of selected peak heights; second, as
LPCB or HPCB values, representing total PCBs ac-
tually present in the specified ranges, determined by
applying appropriate conversion factors to each re-
ported Aroclor value (27); third, as total PCBs (TPCB),
the sum ofthe LPCB and HPCB values obtained from
the Aroclor 1242 and 1260 values, respectively; and
fourth, as serum lipid PCB values, obtained by dividing
the serum LPCB, HPCB, or TPCB values by the total
serum neutral lipid. Also shown are the corresponding
data for p,p'-DDE, which was present at background
levels.
Reference values were obtained on 25 office workers
in a Connecticut office in 1979. Their geometric mean
analytical values were for serum Aroclor 1242, 6.6 ppb;
for Aroclor 1254, 14.4 ppb; for Aroclor 1260, 8.3 ppb;
for p,p'-DDE, 11.3 ppb. Thus, taking the correction
factor x for the 1976 data as 10, the mean xenobiotic
levels in the study population in 1976 and 1979 were,
forAroclor 1242, about220and40timesthebackground
levels, respectively; for Aroclor 1254 and 1260, about
4-6timesthebackground; andforDDE, aboutthe same
as background.
Also for x = 10, Table 3 indicates that in the 44 to
45months betweenthe 1976 and 1979examinations, the
geometric mean level of serum Aroclor 1242 fell from
1470 to 277ppb, or81%, and that ofserum Aroclor 1254
from 84 to 55 ppb, or 35%. Both calculations must be
taken with caution, given the imprecision of the ana-
lysis, since they are uncorrected for changes in the
composition of the study population and highly depen-
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FIGURE 1. Serum triglyceride levels (mg/dL) in the study popula-
tion. Cross-hatched area indicates values falling above the 95th
percentile for age from the Lipid Research Clinics Prevalence
Study (31).
dent upon the estimated value ofthe correction factor,
x. The implied extent ofclearance ofretained LPCB is
less sernsitive to the estimated value of x, but more
difficult to interpret, since some direct exposure to Ar-
oclor 1016continuedduringthefirstthirdoftheinterval
between the examinations. Investigation ofthe rates of
clearance of individual PCB isomers in this population
iS conti1nuing.
Because of the analytical uncertainties in the 1976
serum PCB data, we also examined two other measures
ofPCB exposure, namely, the estimates ofrelative ex-
posure based onanalysis ofthe individualjob activities,
and the measurements ofPCB air levels in the various
working areas, made at the time of the 1976 examina-
tion. The correlations of these measures with the 1976
and 1979 serum LPCB and HPCB values are shown in
Table 4.
The measurements of area air levels proved to be a
poor estimate ofexposure, and were dropped from fur-
ther consideration in the regressions against clinical
variables. Therelative exposureestimateshowed ahigh
correlation with serum LPCB in 1976 (r = 0.73, de-
clining to 0.51 in 1979), indicating that it reflected es-
timated current exposure to Aroclor 1016, which was
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FIGURE 2. Serum total cholesterol levels (mg/dL) in the study pop-
ulation. Cross-hatched areas indicate valuesfallingabove the 95th
percentile for age from the Lipid Research Clinics Prevalence
Study (31).
in use at the time. The correlations between the ex-
posure estimate and the serum HPCBs were lower but
equal in 1976 and 1979 (r = 0.36).
Relationships of Independent Variables to
PCB Exposure
The correlation coefficients for the association ofthe
individual independent variables selected for the re
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Table 3. Distributions of serum PCB and DDE in study population of PCB-exposed capacitor workers.
1976 1979
log
Descriptor of serum mean Percentiles log Percentiles
parameter - log x' ± SD GM' MV' mean ± SD GM' 9 Mv
Measures of lower PCBs
Aroclor 1242, ppb 2.167 0.486 147.1x 23.4x 926.2x 9 2.443 0.463 277.1 48.1 1598.1 1
LPCB, ppb 1.560 0.481 36.3x 5.7x 226.9x 9 1.832 0.463 67.9 11.8 391.6 1
Lipid LPCB, ppm 0.968 0.474 9.3x 1.5x 56.3x 9 1.245 0.432 17.6 3.4 90.3 1
Measures of higher PCBs
Aroclor 1254, ppb 0.924 0.414 8.4x 1.8x 40.3x 9 1.740 0.442 54.9 10.3 292.4 1
Aroclor 1260, ppb 1.543 0.447 34.9 6.4 190.0 30
HPCB (1254), ppb 0.472 0.411 3.Ox 0.6x 14.2x 9 1.285 0.442 19.3 3.6 107.7 1
HPCB (1260), ppb 1.375 0.447 23.7 4.4 129.2 30
Lipid HPCB (1254), ppm - 0.120 0.396 0.8x 0.2x 3.4x 9 0.695 0.400 5.0 1.1 22.7 1
Lipid HPCB (1260), ppm 0.785 0.406 6.1 1.3 28.6 30
Measures of total PCBs
TPCB (1242, 1260), ppb 1.979 0.437 95.2 18.2 499.0 30
Lipid TPCB, ppm 1.392 0.405 24.6 5.3 114.4 30
Measures of p,p'-DDE
DDE, ppb 0.033 1.08x 27 1.005 0.318 10.1 3.0 33.7 1
Lipid DDE, ppm 0.305 0.284 2.0 0.7 6.0 1
a GM = geometric mean; MV = missing values.
bMost likely value oflog x = 1.0; x = 10.
Table 4. Correlation coefficients for associations between serum PCB
levels, area air levels, and the job analysis exposure estimate in 1976 and 1979.
1976 1979
Exposure Area air Exposure Area air
estimate level estimate level
(N = 181) (N = 180) (N = 172) (N = 100)
LPCBs (1242)
Gross serum conen. 0.731 0.144 0.506 - 0.014
Serum lipid conen. 0.727 0.167 0.516 0.029
HPCBs (1254)
Gross serum concn. 0.368 0.080 0.360 - 0.029
Serum lipid concn. 0.360 0.102 0.369 0.010
HPCBs (1260)
Gross serum concn. 0.359 - 0.025
Serum lipid conen. 0.363 0.014
Exposure estimate 1.0 - 0.084 1.0 - 0.164
gression study with the various measures of PCB ex-
posure, as obtained by simple regression, are shown in
Table 5.
The tabulated data indicated strong associations of
age and/or service time with HPCBs in both 1976 and
1979, and with LPCBs in 1979, probably reflecting a
time-dependent accumulation ofthe more slowly me ta-
bolized PCB isomers. There were significant negative
correlations between the body mass index and the serum
lipid LPCB in 1976 and significant positive correlations
with the gross serum LPCBs and HPCBs in 1979. In
1979, LPCB values were significantly higher in females
than males (positive sign of coefficient) but lower in
smokers (negative sign), probablyreflectingoxidase in-
duction (32). 1979 PCB levels in retirees were not sig-
nificantlydifferentfromthose inworkerswhocontinued
in employment. Urinary specific gravity (SPG) and the
presenceofdiabetes oralcoholismshowednoassociation
with serum PCB levels, but SPG was the one inde-
pendent variable showingassociation with the exposure
estimate in 1976. Higher levels of LPCBs were found
in nonfasting individuals in 1976.
Relationships of Clinical Laboratory
Findings to PCB Exposure
Tables 6, 7, 8 and 9 show the results ofapplying the
three regression procedures to the clinical laboratory
findings using as independent variables the 1976 and
1979 levels ofLPCB, HPCB, and DDE (each expressed
as both the log gross serum and log serum lipid value
except for DDE in 1976), and the PCB exposure esti-
mate (EXE), respectively. In each case, we have tab-
ulated the regression coefficients for the associations
with PCB or DDE, 1, and their confidence intervals
for those clinical parameters that showed a significant
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lTble 5. Correlation coefficients relating measures of PCB
exposure and the selected independent variables.
Independent variables
Dependent variable Age Ser Sex SPG BMI DS SC FNF JS
Gross serum PCBs
LPCBs, 1976 0.107 0.073 0.011 - 0.121 - 0.090 - 0.045 - 0.132 - 0.188*
LPCBs, 1979 0.259* 0.191* 0.160* 0.084 0.208* 0.096 - 0.173* - 0.015
HPCBs, 1976 0.421* 0.394* - 0.091 - 0.111 - 0.013 - 0.086 0.009 - 0.021
HPCBs, 1979 0.516* 0.549* -0.026 0.037 0.189* 0.141 -0.050 0.005
Serum lipid PCBs
LPCBs, 1976 0.028 -0.007 0.030 - 0.111 -0.172* - 0.121 -0.172* - 0.211*
LPCBs, 1979 0.209* 0.140 0.185* 0.077 0.136 0.061 -0.199* - 0.008
HPCBs, 1976 0.340* 0.314* - 0.014 - 0.099 - 0.109 - 0.001 - 0.037 - 0.045
HPCBs, 1979 0.493* 0.535* 0.014 0.026 0.114 0.109 -0.069 0.014
Exposure estimate
1976 0.004 -0.009 - 0.040 - 0.158* - 0.106 - 0.115 -0.109 - 0.138
1979 0.004 - 0.009 - 0.040 - 0.062 - 0.036 - 0.115 - 0.109 0.084
*Statistical significance G 5%.
Table 6A. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum LPCB, as determined by three regression procedures: log gross serum LPCBs.
Log gross serum LPCBsb
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea
' , 5 95 I 5 95 5 95
1976
Log triglycerides 2.14 0.07 0.01 0.14 0.10* 0.03 0.17 0.10* 0.03 0.16
Cholesterol 252 24.9* 8.48 41.4 24.3* 7.15 41.5 25.7* 9.49 42.0
Log SGPT 1.46 0.03 -0.01 0.09 0.07* 0.02 0.13 0.08* 0.02 0.13
Log GGTP 1.10 0.07 -0.01 0.15 0.12* 0.04 0.21 0.13* 0.05 0.21
Log total bilirubin -0.34 -0.09* -0.14 -0.03 -0.08* -0.15 -0.02 -0.09* -0.15 -0.03
Direct bilirubin 0.15 -0.03* -0.06 -0.01 -0.04* -0.06 -0.01 -0.04* -0.06 -0.01
Uric acid 5.73 0.08 -0.31 0.46 0.31 -0.01 0.64 0.35* 0.04 0.66
Log blood glucose 2.01 -0.01 -0.03 0.01 -0.001 -0.02 0.02 -0.001 -0.02 0.01
Phosphorus 3.01 0.14* 0.01 0.27 0.20* 0.04 0.35 0.16* 0.01 0.30
RBC 4.94 -0.07 -0.20 0.06 -0.07 -0.18 0.05 -0.08 -0.19 0.02
Lymphocytes 2.33 0.03* 0.04 0.55 0.42* 0.12 0.71 0.35* 0.07 0.63
1979
Log triglycerides 2.16 0.18* 0.11 0.25 0.15* 0.08 0.22 0.14* 0.07 0.21
Cholesterol 238 34.3* 18.8 49.8 25.6* 8.81 42.4 24.0* 7.90 40.1
Log GGTP 1.20 0.11* 0.03 0.20 0.10* 0.02 0.19 0.12* 0.04 0.20
Log total protein 0.86 0.01* 0.002 0.02 0.01 -0.001 0.02 0.01 -0.001 0.02
Globulin 2.92 0.19* 0.05 0.33 0.10 -0.05 0.24 0.13 -0.005 0.26
Hemoglobin 15.4 -0.04* -0.78 -0.02 -0.20 -0.56 0.16 -0.20 -0.54 0.13
% Lymphocytes 30.9 -0.49 -3.02 2.04 -1.92 -4.69 0.85 -1.44 -4.31 1.00
Monocytes 0.48 0.07* 0.01 0.14 0.09* 0.02 0.17 0.08* 0.01 0.15
% Monocytes 6.96 1.18* 0.38 1.99 1.41* 0.54 2.27 1.41* 0.58 2.23
aSee Table 1 for abbreviations. Asterisk (*) indicates 95% confidence limits did not include zero.
bN (1976) for simple regression = 189-194. N for multiple regresion and step regression = 159-166
except hematology where there are 41 missing values (Table 1).
association in one ofthe six regressions performed. The where the regression coefficient was found to be of sta-
test ofsignificance was that the 95% confidence interval tistical significance, which, depending on the number of
for A, not include zero; statistically significant associa degrees offreedom, generally corresponded to a partial
tions are indicated by asterisks. In addition, in Tables r > 0.15; in addition, we have listed some borderline
6-8we have listed the partial rvalues for the backward associations, as indicated by partial r values of 0.14-
step regressions against the log serum lipid xenobiotic 0.15. A comparison ofthe I,B values across these various
(e.g., LPCB, HPCBorDDE)andthe otherindependent regressions indicates the sensitivity of the relation to
variables. The partial rvalues listed are generally those confounding by the other independent variables, and
174BIOCHEMICAL AND HEMATOLOGICAL FINDINGS IN CAPACITOR WORKERS
Table 6B. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum LPCB, as determined by three regression procedures log serum lipid LPCBs.
Log serum lipid LPCBsa
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea g5 95 I 5 95 I 5 95
1976
Log triglycerides -0.04 -0.11 0.03 0.01 -0.07 0.08 0.01 -0.07 0.08
Cholesterol -1.65 -18.8 15.5 1.82 -16.4 20.1 1.82 -16.4 20.1
Log SGPT -0.002 -0.06 0.06 0.05 -0.01 0.11 0.05 -0.01 0.10
Log GGTP 0.02 -0.06 0.10 0.10* 0.01 0.19 0.11* 0.02 0.19
Log total bilirubin -0.08* -0.04 -0.02 -0.09* -0.15 -0.02 -0.09* -0.15 -0.03
Direct bilirubin -0.03* -0.05 -0.01 -0.04* -0.06 -0.01 -0.04* -0.06 -0.01
Uric acid -0.09 -0.48 0.30 0.25 -0.09 0.59 0.31 -0.02 0.63
Log blood glucose -0.02* -0.04 -0.003 -0.003 -0.02 0.01 -0.003 -0.02 0.01
Phosphorus 0.16* 0.02 0.29 0.22* 0.06 0.38 0.19* 0.04 0.34
RBC -0.01 -0.23 0.03 -0.11 -0.23 0.01 -0.12* -0.23 -0.01
Lymphocytes 0.23* 0.01 0.54 0.38* 0.08 0.69 0.39* 0.09 0.69
1979
Log triglycerides 0.08 -0.01 0.16 0.05 -0.03 0.13 0.04 -0.03 0.12
Cholesterol 12.2 -5.20 29.6 2.64 -15.5 20.8 2.88 -14.7 20.4
Log GGTP 0.07 -0.02 0.16 0.07 -0.02 0.16 0.07 -0.02 0.16
Log total protein 0.007 -0.003 0.02 0.003 -0.01 0.01 0.003 -0.01 0.01
Globulin 0.12 -0.26 0.27 0.02 -0.13 0.17 0.02 -0.13 0.17
Hemoglobin -0.59* -1.00 -0.19 -0.31 -0.69 0.06 -0.32 -0.68 0.03
% Lymphocytes -1.67 -4.38 1.03 -3.26* -6.14 -0.39 -1.95 -4.65 0.75
Monocytes 0.08* 0.01 0.16 0.11* 0.03 0.19 0.10* 0.02 0.17
% Monocytes 1.36* 0.50 2.21 1.61* 0.71 2.52 1.58* 0.71 2.46
a N (1979) for simple regression = 172-174. N for multiple regression and step regression = 165-166.
Table 6C. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum LPCB, as determined by three regression procedures independent variables.
Independent variablesa
Step regression Partial r
Confid. limits Log
Dependent variablea
' 5 95 Age Sex SPG BMI DS SC JS FNF (LPCB)sL
1976
Log triglycerides 0.01 -0.07 0.08 0.20 -0.22 -0.15 0.28 0.26 X
Cholesterol 1.82 -16.4 20.1 0.35 0.20 X
Log SGPT 0.05 -0.01 0.10 -0.29 0.35 X
Log GGTP 0.11* 0.02 0.19 -0.19 0.15 0.15 X 0.29 0.20
Log total bilirubin -0.09* -0.15 -0.03 0.20 -0.19 X -0.22
Direct bilirubin -0.04* -0.06 -0.01 -0.17 -0.16 -0.20 X 0.17 -0.21
Uric acid 0.31 -0.02 0.63 -0.47 0.45 X 0.16
Log blood glucose -0.003 -0.02 0.01 0.14 0.32 0.39 X 0.19
Phosphorus 0.19* 0.04 0.34 0.16 X 0.19
RBC -0.12* -0.23 -0.01 -0.58 X -0.17
Lymphocytes 0.39* 0.09 0.69 X 0.16 0.23
1979
Log triglycerides 0.04 -0.03 0.12 0.19 0.40 X
Cholesterol 2.88 -14.7 20.4 0.34 0.18 X
Log GGTP 0.07 -0.02 0.16 0.16 -0.26 0.18 0.21 X
Log total protein 0.003 -0.01 0.01 -0.14 0.23 0.19 X
Globulin 0.02 -0.13 0.17 0.27 -0.15 X
Hemoglobin -0.32 -0.68 0.03 -0.54 X
% Lymphocytes -1.95 -4.65 0.75 0.19
Monocytes 0.10* 0.02 0.17 0.21 -0.21 X 0.20
% Monocytes 1.58* 0.71 2.46 -0.16 -0.15 -0.23 X 0.27
a See text for abbreviations.
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Table 7A. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum HPCB (1254), as determined by three regression procedures: log gross serum HPCBsac
Log gross serum HPCBs
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea z , 5 95 I3 5 95 5 95
1976
Log triglycerides 2.14 0.13* 0.06 0.21 0.11* 0.01 0.20 0.12* 0.04 0.21
Cholesterol 251.9 38.7* 19.8 57.6 31.1* 7.63 54.6 35.1* 13.1 57.1
Log SGPT 1.46 0.04 -0.03 0.11 0.08* 0.002 0.15 0.06 -0.003 0.13
Log GGTP 1.10 0.12* 0.03 0.21 0.15* 0.03 0.26 0.15* 0.05 0.25
Log alk. phos. 1.42 0.07* 0.02 0.11 0.06 -0.004 0.13 0.07* 0.01 0.12
Log total bilirubin -0.34 -0.08* -0.15 -0.02 -0.12* -0.21 -0.03 -0.10* -0.18 -0.03
Direct bilirubin 0.15 -0.03 -0.05 0.001 -0.04* -0.08 -0.006 -.0.04* -0.07 -0.008
Log total protein 0.86 -0.002 -0.01 0.01 -0.01 -0.02 0.01 -0.006 -0.02 0.01
Log albumin 0.65 -0.01 -0.02 0.003 -0.008 -0.02 0.007 -0.007 -0.02 0.008
Log BUN 1.19 0.04* 0.001 0.09 0.02 -0.04 0.06 0.02 -0.03 0.06
Creatinine 1.30 -0.01 -0.09 0.06 -0.06 -0.15 0.03 -0.05 -0.13 0.04
Log B/C ratio 1.08 0.05* 0.002 0.09 0.04 -0.02 0.09 0.04 -0.01 0.08
Iron 110.7 -13.6* -26.1 -1.16 -10.5 -27.3 6.33 -10.1 -24.1 4.14
RBC 4.94 -0.08 -0.23 0.07 -0.06 -0.21 0.10 -0.09 -0.22 0.04
WBC 7.0 1.00* 0.40 1.59 1.34* 0.55 2.14 0.95* 0.28 1.63
Lymphocytes 2.33 0.33* 0.02 0.63 0.72* 0.29 1.15 0.70* 0.27 1.13
% Monocytes 4.37 -.1.07* -1.91 -0.23 -.1.08* -2.98 -0.63 -1.67 -2.61 -0.73
1979
Log triglycerides 2.16 0.22* 0.15 0.29 0.19* 0.10 0.27 0.19* 0.12 0.26
Cholesterol 238.2 47.3* 31.6 63.0 36.1* 15.9 56.3 39.4* 20.7 58.2
Log GGTP 1.20 0.14* 0.05 0.22 0.07 -0.03 0.17 0.10* 0.02 0.19
Log alk. phos. 1.47 0.06* 0.02 0.10 0.04 -0.01 0.10 0.05* 0.01 0.10
Direct bilirubin 0.14 -0.02 -0.05 0.004 -0.02 -0.05 0.01 -0.02 -0.05 0.001
Log blood glucose 2.00 0.04 -0.02 0.06 0.02 -0.003 0.04 0.02* 0.003 0.04
Globulin 2.92 0.21* 0.07 0.36 0.11 -0.07 0.29 0.12 -0.02 0.27
Log A/G ratio 0.18 -0.04* -0.06 -0.01 -0.01 -0.04 0.02 -0.01 -0.04 0.02
Log BUN 1.23 0.08* 0.04 0.12 0.04 -0.001 0.09 0.05* 0.005 0.09
Log B/C ratio 1.11 0.06* 0.02 0.11 0.03 -0.02 0.09 0.04 -0.01 0.09
Monocytes 0.48 0.08* 0.01 0.16 0.10* 0.01 0.19 0.08* 0.01 0.16
% Monocytes 6.96 1.23* 0.38 2.07 1.32* 0.25 2.38 1.13* 0.27 1.99
aSee Table 6 footnotes.
the effects of conversion from gross
lipid concentration ofthe xenobiotic.
serum to serum
The most consistent finding in Tables 6-9 was the
strong, positive associations of log serum triglycerides
and cholesterol with the log gross serum level ofPCBs
and DDE which has been found by others (13,15,21,22).
The association disappeared when the xenobiotic level
was expressed as the concentration in serum lipids, or
as the PCB exposure estimate. This disappearance was
associated with a 70 to 130% decline in the value of'Pi.
This finding was exhibited in all regressions whether
against log LPCB, HPCB, or DDE, and whether for
1976 or 1979. A similar, but less dramatic change was
exhibited by regressions against measures of the he-
patic enzymes (log GGTP, log SGPT and log alkaline
phos phatase). These parameters frequently showed
signifi cant associations with the log gross serum levels
of PCB or DDE, but the values dropped 20 to 50%
upon conversion to serum lipid levels. The only asso-
ciations thenremainingsignificant in the finalbackward
step regressions were those of 1976 log GGTP with log
LPCB, log HPCB, and EXE. None ofthe other clinical
parameters showed consistent declines of this magni-
tude in '.
A second consistent finding was strong negative as-
sociations of PCBs, but not DDE, with the two meas-
ures ofbilirubin, direct bilirubin and log total bilirubin,
in 1976. These associations were seen for all measures
of log PCB (LPCB, HPCB and EXE) in almost all of
the regressions. Only two associations remained in 1979
(HPCB, EXE), when the PCB levels were lower.
A third set of findings consisted of associations be-
tween the hematological variables and the serum lipid
PCBs. In 1976 significant negative associations were
found between RBCs and both log serum lipid LPCB
and HPCB, and between the monocytes and both log
serum lipid HPCB and the exposure estimate. There
werepositiveassociationsbetweenlymphocytes andlog
serum lipid LPCB, and between WBCs and log serum
lipid HPCB. Similar associations with the log gross
serum DDE were found for the lymphocytes, mono-
cytes, and WBCs. In separate step regression studies
log total bilirubin was selected in place of log serum
lipid PCB values in the cases ofRBCs and the lympho-
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Table 7B. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum HPCB (1254), as determined by three regression procedures: log serum lipid HPCBs.
Log serum lipid HPCBs
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea f3l 5 95 I 5 95 5 95
1976
Log triglycerides -0.02 -0.10 0.06 -0.07 -0.17 0.03 -0.08 -0.17 0.02
Cholesterol 2.68 -17.8 23.2 -11.1 -35.3 13.1 -11.5 -35.6 12.6
Log SGPT -0.01 -0.08 0.06 0.03 -0.04 0.11 0.03 -0.04 0.10
Log GGTP 0.06 -0.04 0.16 0.09 -0.02 0.21 0.11* 0.002 0.21
Log alk. phos. 0.04 -0.02 0.09 0.02 -0.04 0.09 0.03 -0.03 0.09
Log total bilirubin -0.08* -0.15 -0.01 -0.12* -0.21 -0.03 -0.11* -0.19 -0.02
Direct bilirubin -0.02 -0.05 0.005 -0.04* -0.07 -0.001 -0.03* -0.07 -0.002
Log total protein -0.005 -0.02 0.01 -0.01 -0.03 0.01 -0.015* -0.03 -0.003
Log albumin -0.01 -0.02 0.002 -0.01 -0.03 0.002 -0.014* -0.028 -0.001
Log BUN 0.03 -0.01 0.07 0.003 -0.05 0.05 0.003 -0.05 0.05
Creatinine -0.05 -0.1 0.03 -0.10* -0.18 -0.01 -0.09* -0.18 -0.01
Log B/C ratio 0.05* 0.002 0.09 0.04 -0.02 0.09 0.04 -0.01 0.09
Iron -15.2* -28.1 -2.21 -13.1 -29.9 3.77 -13.2 -28.2 1.74
RBC -0.13 -0.28 0.03 -0.12 -0.28 0.03 -0.15* -0.29 -0.02
WBC 0.97* 0.35 1.59 1.20* 0.39 2.01 0.98* 0.26 1.69
Lymphocytes 0.30 -0.02 0.62 0.58* 0.14 1.02 0.36 -0.02 0.74
% Monocytes -0.87 -1.77 0.02 -1.45* -2.64 -0.60 -1.61* -2.63 -0.59
1979
Log triglycerides 0.11* 0.03 0.20 0.04 -0.06 0.13 0.04 -0.06 0.13
Cholesterol 25.3* 6.72 43.9 2.06 -20.1 24.2 2.19 -19.6 24.0
Log GGTP 0.09 -0.01 0.19 0.02 -0.09 0.13 0.02 -0.09 0.13
Log alk. phos. 0.05* 0.003 0.10 0.03 -0.03 0.08 0.03 -0.01 0.08
Direct bilirubin -0.02 -0.05 0.004 -0.02 -0.06 0.01 -0.03* -0.06 -0.002
Log blood glucose 0.04* 0.02 0.06 0.02 -0.01 0.04 0.02 -0.005 0.04
Globulin 0.14 -0.02 0.31 -0.004 -0.19 0.18 -0.004 -0.19 0.18
Log A/G ratio -0.02 -0.04 0.01 0.001 -0.03 0.04 0.001 -0.03 0.04
Log BUN 0.08* 0.03 0.12 0.04 -0.01 0.08 0.04 -0.003 0.09
Log B/C ratio 0.05* 0.01 0.10 0.02 -0.03 0.08 0.02 -0.03 0.08
Monocytes 0.10* 0.03 0.18 0.12* 0.03 0.22 0.11* 0.03 0.19
% Monocytes 1.48* 0.55 2.41 1.56* 0.44 2.69 1.42* 0.48 2.36
aSee Table 6 footnotes.
cytes. Similar selections, reflecting similar co lineari-
ties, occurred in the cases of phosphate (with LPCB)
and creatinine (with HPCB). Smoking was a significant
confounding variable in the cases of direct bilirubin,
WBCs, and phosphate.
In 1979 strong positive associations were found be-
tween all measures of exposure to PCB (but not DDE)
and the absolute and relative monocyte levels. The bil-
irubins did not replace PCBs in the step regressions,
but smoking was a significant confounder. The positive
associations of cholesterol and serum sodium with the
relative exposure estimate in 1976 and the negative as-
sociation of log serum lipid DDE with serum iron in
1979 appeared to be singular findings.
The 1530 regressions used togenerate thedata shown
inTables 6-9 showed atleast one significant association
(5% level) with one measure of exposure in one of the
regressions for 26 of the 42 clinical variables. The in-
cidence of significant associations with the clinical var-
iables was positively influenced by the number of
independent variables included in the regressions. The
independent variables used in Tables 6-9 regressions
all showed multiple associations with the clinical labo-
ratory parameters. This group ofindependent variables
did not, however, include measures of alcohol con-
sumption or socioeconomic status, both of which have
been used in other studies (21,22). The data available
indicates that there can be important colinearities among
the dependent variables. Because of the uncertainties
presented by chance associations, unused or unidenti-
fied confounders, and colinearities among variables we
have focussed our interpretations upon those associa-
tions that were seen consistently in the step regressions
against log serum lipid PCBs, but not in the corres
ponding regressions against log DDE.
The mean I coefficients of Tables 6-9 express the
best estimates of the dependence of the clinical labo-
ratory variables on log PCB, and their 95% confidence
limits indicate the uncertainties ofthese estimates. For
associations observed to be statistically significant we
have multiplied the lower and upper P, confidence limit
values by the observed range of log PCBs in order to
determine whether the product resulted in values for
the laboratory variables outside the normal expected
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Table 7C. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum HPCB (1254), as determined by three regression procedures: independent variables.
Independent variablesa
Partial r
Log
Dependent variable Age Sex SPG BMI DS SC JS FNF (HPCB)SL
1976
Log triglycerides 0.20 -0.22 -0.15 0.28 0.26 X
Cholesterol 0.35 0.20 X
Log SGPT -0.29 0.37 X
Log GGTP -0.18 0.19 X 0.28 0.16
Log alk. phos. 0.14 x
Log total bilirubin 0.21 -0.17 X 0.15 -0.20
Direct bilirubin -0.17 -0.17 X 0.19 -0.17
Log total protein -0.16 -0.17 X -0.19
Log albumin -0.27 -0.16 X -0.17
Log BUN 0.16 0.34 0.19 X
Creatinine 0.19 -0.40 0.23 X -0.17
Log B/C ratio 0.17 X
Iron 0.20 -0.15 X
RBC -0.59 X 0.18
WBC 0.29 X 0.21
Lymphocytes X 0.16
% Monocytes X -0.27 -0.27
1979
Log triglycerides 0.21 0.40 X
Cholesterol 0.35 0.19 X
Log GGTP 0.18 -0.28 0.19 0.23 X
Log alk. phos. 0.14 X
Direct bilirubin -0.16 -0.15 X -0.14
Log blood glucose 0.29 0.16 0.38 X
Globulin 0.27 0.15 X
Log A/G ratio -0.21 -0.24 -0.16 X
Log BUN 0.20 0.34 0.23 X
Log B/C ratio 0.26 0.30 X
Monocytes 0.19 -0.21 X 0.21
% Monocytes -0.24 X 0.23
ranges. For these criteria, the only variables having
statistical significance outside the normal ranges were
the 1976percentlymphocytes andthe 1979percentmon-
ocytes. For all other parameters the observed associ-
ations with log PCB levels reflected variations within
the normal laboratory ranges.
Figures 3 and 4 show partial residual plots for two
laboratory variables, log total bilirubin in 1976 and the
percent monocytes in 1979, as calculated at the end of
the stepwise regression, plotted against log serum lipid
LPCB. They represent plots of a predictor variable
against the dependent variable with the "effects" ofall
otherpredictor variables statistically removed (33). For
the logtotal bilirubin data ofFigure 3, the partial rwas
-0.22 (p = 0.01) and I3 about -0.09 log units/decade of
LPCB (Table 6). For 2.2 decades of LPCB, the range
of the P, product was -0.07 to -0.33 (mean = -10.2).
When controlled for confounders, all study data (Fig.
3) fell between 0.1 and 1.0 mg/dL (mean = 0.3 mg/dL),
which is within the normal range (Table 1).
As shown in Figure 4 the 1979 percent monocyte data
were more tightly grouped (partial r = 0.28), and the
I,3 estimate was 1.38%/LPCB decade. For the 2.5 dec-
ade range of LPCB, the range of 3,B products corre-
sponded to an increment in percent monocytes of 1.8 to
6.2% (mean = 3.5%). Inspection ofthe histogram along
the monocyte axis indicates a range of percent mono-
cytes from 5.5 to 15.5% (mean = 10.5%) rather than
the normal range of 0 to 8% (Table 1).
Discussion
PCB Levels in the Study Population
This investigation has shown that certain former op-
erations in capacitor manufacturing presented high ex-
posures to PCBs, particularly during the 1954-1977
periodwhenthemorevolatilelowerPCBs(Aroclor 1242
and 1016) wereinextensiveuse. DuringthisperiodPCB
air levels in the affected working areas were probably
at least the 690 ,ug/m observed in 1975, accompanied by
extensive dermal contact as well.
In our study population, selected so as to include those
working in or near the plant PCB exposure zone, the
mean serum lipid LPCB level in 1976 (Table 3) was
estimated to be 93 ppm (5-95% range, 15-560 ppm),
adjusted for a factor of 10 analytical error. This serum
lipid value corresponded to a mean body burden of 2.0
g (0.3-12.3 g) for the population mean body weight of
77 kg (22 kg offat). These retained LPCBs were com-
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Table 8A. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum p, p'-DDE, as determined by three regression procedures: log gross serum DDE.a
Log gross serum DDE
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea x 5 95 I 5 95 5 95
1976
Log triglycerides 2.13 0.08* 0.05 0.11 0.07* 0.03 0.10 0.08* 0.05 0.11
Cholesterol 251.3 12.7* 5.05 20.4 8.37 -0.13 16.9 10.1* 2.00 18.2
Log GGTP 1.09 0.04* 0.002 0.08 0.02 -0.02 0.06 0.03 -0.01 0.07
Log alk. phos. 1.42 0.04* 0.02 0.06 0.04* 0.02 0.07 0.04* 0.02 0.07
Log total protein 0.86 0.002 -0.002 0.006 0.009 -0.001 0.009 0.005* 0.001 0.009
WBC 7.02 0.33* 0.08 0.57 0.41* 0.12 0.70 0.35* 0.08 0.62
Lymphocytes 2.33 0.23* 0.11 0.34 0.30* 0.16 0.44 0.26* 0.13 0.40
% Lymphocytes 33.8 1.42 -0.11 2.95 2.04* 0.17 3.91 1.37 -0.38 3.11
% Monocytes 4.38 -0.36* -0.70 -0.02 -0.40 -0.80 0.004 -0.46* -0.83 -0.08
1979
Log triglycerides
Cholesterol
Log alk. phos.
Log total protein
Log albumin
Globulin
Log A/G ratio
Serum Ca
Serum Iron
aSee Table 6 footnotes.
2.16 0.31* 0.21 0.41 0.28* 0.18 0.38 0.30* 0.21 0.39
238.2 48.6* 25.8 71.5 32.6* 7.56 57.6 30.4* 6.07 54.7
1.47 0.09* 0.04 0.15 0.09* 0.03 0.15 0.10* 0.04 0.16
0.86 0.01 -0.004 0.02 0.01* 0.001 0.03 0.01 -0.001 0.03
0.64 -0.02* -0.03 -0.01 -0.006 -0.02 0.01 -0.006 -0.02 0.01
2.92 0.30* 0.10 0.50 0.23* 0.02 0.44 0.24* 0.04 0.43
0.18 -0.06* -0.09 -0.02 -0.03 -0.07 0.01 -0.03 -0.07 0.01
9.67 -0.02 -0.22 0.18 -0.10 -0.33 0.13 -0.08 -0.29 0.13
108.6 -10.3 -24.3 3.68 -10.0 -25.5 5.50 -8.81 -22.9 5.30
Table 8B. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum p, p'-DDE, as determined by three regression procedures: log serum lipid DDE.a
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits
Dependent variablea 5 95 l 5 95 l5 95
1976
Log triglycerides
Cholesterol
Log GGTP
Log alk. phos.
Log total protein
WBC
Lymphocytes
% Lymphocytes
% Monocytes
1979
Log triglycerides 0.08 -0.04 0.20 0.06 -0.06 0.18 0.07 -0.04 0.19
Cholesterol -3.10 -29.7 23.5 -20.8 -47.9 6.34 -21.6 -47.9 4.76
Log alk. phos. 0.07* 0.002 0.13 0.07 -0.002 0.13 0.08* 0.01 0.14
Log total protein -0.003 -0.02 0.01 0.001 -0.01 0.02 0.001 -0.01 0.02
Log albumin -0.02* -0.04 -0.004 -0.01 -0.03 0.008 -0.01 -0.03 0.007
Globulin 0.15 -0.08 0.38 0.07 -0.16 0.30 0.08 -0.15 0.30
Log A/G ratio -0.04 -0.08 0.002 -0.01 -0.06 0.03 -0.02 -0.06 0.03
Serum Ca -0.17 -0.39 0.06 -0.24* -0.48 -0.001 -0.22 -0.45 0.008
Serum Iron -19.7* -35.0 -4.43 -19.6* -36.0 -3.20 -17.5* -33.1 -2.00
aSee Table 6 footnotes.
posed almost entirely of PCB isomers with gas chro- of serum lipid LPCB values with length of service in-
matographic peaks having retention times (relative to dicated no significant statistical association, so that
DDE = 100) of 37, 71 and 84 (27,34), the other LPCB steady state levels appeared to have been reached within
components ofAroclors 1016 and 1242 beingmuch more the first few years of employment. Thus, the levels of
readily metabolized in the human. Regression studies retained LPCBs observed in 1976 could have been rep-
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Table 8C. Regression and correlation coefficients for 1976 and 1979 clinical variables showing at least one significant association with
a measure of serum p, p'-DDE, as determined by three regression procedures: independent variables.
Independent variables
Partial r
Log
Dependent variable Age Sex SPG BMI DS SC JS FNF (DDE)
1976
Log triglycerides 0.29 0.27 0.38
Cholesterol 0.31 0.20 0.19
Log GGTP -0.19 0.17 0.26
Log alk. phos. 0.31
Log total protein -0.23 -0.17 0.16
WBC 0.25 0.20
Lymphocytes -0.16 0.33
% Lymphocytes
% Monocytes 0.16 -0.25 -0.21
1979
Log triglycerides 0.21 0.40
Cholesterol 0.35 0.19
Log alk. phos. 0.14 0.18
Log total protein -0.14 0.23 -0.19
Log albumin -0.21 -0.15
Globulin 0.27 0.15
Log A/G ratio -0.21 -0.24 -0.16
Serum Ca 0.15
Serum Iron -0.20 -0.17
aSee Table 6 footnotes.
Table 9. Regression coefficients for 1976 and 1979 clinical variables showing at least one significant association with a estimate ofrelative
exposure to PCB in 1976 (EXE), as determined by three regression procedures.a
Simple regression Multiple regression Step regression
Confid. limits Confid. limits Confid. limits Partial
Dependent variablea N x 5 95 I 5 95 5 95 (EXE)
1976
Cholesterol 193 251.3 7.86 -1.33 17.0 9.62 -0.16 19.4 10.5* 1.26 19.7 0.18
Log GGTP 192 1.09 0.03 -0.01 0.10 0.06* 0.01 0.10 0.06* 0.01 0.10 0.20
Log total bilirubin 194 -0.34 -0.04* -0.08 -0.01 -0.05* -0.09 -0.02 -0.05* -0.08 -0.01 -0.20
Direct bilirubin 193 0.15 -0.01 -0.02 0.002 -0.02* -0.03 -0.001 -0.02* -0.03 -0.001 -0.17
Log blood glucose 193 2.01 -0.01* -0.02 -0.004 -0.01 -0.02 0.003 -0.01 -0.02 0.001
Log A/G ratio 191 0.21 0.02* 0.001 0.03 0.01 -0.005 0.03 0.01 -0.004 0.03
Serum Na 192 139.5 -0.10 -0.55 0.34 -0.54* -1.02 -0.06 -0.53* -0.98 -0.08 -0.18
Serum iron 192 112.1 -6.35* -12.3 -0.36 -3.89 -10.8 3.00 -4.23 -10.8 2.30
Lymphocytes 153 2.33 0.14 -0.01 0.28 0.19* 0.02 0.36 0.15 -0.01 0.31
Monocytes 153 0.31 -0.01 -0.05 0.02 -0.01 -0.04 0.03 -0.01 -0.04 0.03
% Monocytes 153 4.38 -0.34 -0.74 0.06 -0.35 -0.82 0.11 -0.46* -0.90 -0.02
1979
Cholesterol 174 238.5 4.72 -4.09 13.5 4.83 -3.91 13.6 4.94 -3.43 13.3
Log GGTP 174 1.20 0.01 -0.03 0.06 0.02 -0.02 0.07 0.02 -0.02 0.07
Log total bilirubin 174 -0.22 -0.02 -0.05 0.01 -0.03* -0.06 -0.001 -0.03* -0.06 -0.004 -0.18
Direct bilirubin 174 0.14 -0.01 -0.02 0.01 -0.01 -0.03 0.003 -0.01 -0.03 0.001
Log blood glucose 174 2.00 -0.004 -0.01 0.01 -0.001 -0.01 0.01 -0.002 -0.01 0.01
Log A/G ratio 174 0.18 -0.003 -0.02 0.01 -0.006 -0.02 0.07 -0.005 -0.02 0.01
Na 174 139.4 -0.05 -0.46 0.37 -0.02 -0.43 0.40 -0.02 -0.43 0.39
Iron 172 108.5 -0.96 -6.17 4.25 -0.78 -6.17 4.62 -0.78 -6.17 4.62
Lymphocytes 175 2.09 -0.03 -0.14 0.08 -0.03 -0.16 0.09 -0.03 -0.14 0.09
Monocytes 175 0.48 0.04* 0.001 0.08 0.04* 0.004 0.08 0.05* 0.01 0.08 0.18
% Monocytes 175 6.9 0.58 0.14 1.03 0.61* 0.17 1.05 0.64* 0.20 1.07 0.22
aSee footnotes to Table 6.
resentative ofthose present throughout the Aroclor 1242 burden of 0.2 g (0.04-0.7 g). These HPCBs were com-
and 1016 periods of use. posed primarily of penta- and hexachlorobiphenyl iso-
The mean serum HPCB level in 1976 was estimated mers (27,34,35) resulting either from exposures to
to be 8 ppm (2-34 ppm), corresponding to a mean body Aroclor 1242(whichcontained afewpercentofthelower
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FIGURE 3. Partial residuals for log total bilirubin in 1976 following
final step regression (Table 6) vs. log serum lipid LPCBs. Histo-
grams are shown along each axis. The number of values in the
cells are given by the numerals.
HPCBs), or from earlier exposures to Aroclor 1254.
Their levels were significantly associated with length of
service, so that the upper 5% ofHPCB levels observed
in 1976 (long service, directly exposed workers) may be
representative ofthe exposed population in 1954, at the
end of the period when Aroclor 1254 was the major
dielectric fluid used.
The Aroclor 1242 values reported to us by the analyst
were approximately4timesthe calculated LPCB values
(Table 3). We have shown elsewhere that the minimum
initial concentrations of Aroclors 1016 plus 1242 re-
quired to account for the most persistent LPCB peaks
were about 7.5 times the residual LPCB levels (27).
Thus, the minimal LPCB uptake by the study popula-
tion maybe estimated as 15 g(2.5-92 g). Thisestimated
uptake is a minimum since even the most persistent
LPCB peaks have a finite clearance rate (unpublished
observations). The longer service employees could have
absorbed several times this minimal PCB uptake, but
until better data on PCB clearance becomes available,
actual cumulative LPCB uptakes cannot be estimated
more precisely.
The meanLPCBbodyburdenin 1979(29monthsafter
discontinuance ofmajor exposure) was estimated as 0.4
g (0.7-2.0 g), indicating a clearance of80%. The serum
lipid HPCB means in 1976 and 1979 were within the
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FIGURE 4. Partial residuals for % monocytes in 1979 following final
step regression (Table 6) vs. log serum lipid LPCBs. Histograms
are shown along each axis. The number of values in the cells are
given by the numerals.
error band of the analytical technique (27) and a con-
clusionofsignificantclearanceisprobablyunwarranted.
Chen (35) has reported clearance rates for various pen-
tachlorobiphenyl isomers in Taiwanese Yusho patients
that appear to be at least 10-fold greater than we ob-
served in capacitor workers (27); however, such clear-
ance might be related to P-448 oxidase induction by
PCDFsintheYushopatients. Althoughtheseestimates
of PCB fat levels and uptakes are only approximate,
they serve to define the dose ranges within which the
observed responses can be ascribed.
PCB Effects on Serum Lipids and Serum
Enzymes
Previous investigators have reported statistical as-
sociations between log gross serum levels ofPCBs and
the serum levels of triglycerides, total cholesterol and
certain serum enzymes. Our findings were in general
agreement with such reports. We found significant as-
sociations of log serum triglycerides and total choles-
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terol with every measure oflog gross serum PCBs and
DDE in the final step regressions. Similar associations
were found for log GGTP, and in some cases for log
SGPT, with log gross serum PCBs, and for log alkaline
phosphatase with log gross serum DDE.
It is now evident, however, that such associations
arise because the level of PCBs in the serum is itself
determined by that of the serum lipids (23,24). When
the PCB concentrations were expressed as levels in
serum lipids, which would be expected tocorrelate with
the pharmacological activities (24,25), all the associa-
tions between serum lipids or enzymes and log gross
serum LPCB, HPCB or DDE disappeared except for
those between log GGTP and log PCBs, and between
logalkaline phosphatase and log DDE. Similarly, Chase
et al. (13), who reported associations with gross serum
PCBs, found no significant correlation between either
serum triglycerides or SGOT and the adipose tissue fat
biopsy PCB levels. Although elevated levels of serum
triglycerides, total cholesterol and SGPT were found in
ourstudypopulation (Table3), serumGGTPlevels were
generally in the normal range, and the regression stud-
ies indicated stronger associations with obesity (body
mass index).
PCB Effects on Microsomal Enzymes
Elevated serum GGTP levels have been prominently
mentioned in the literature as an index of microsoinal
enzyme induction in the human (36-40). Recent studies
(41), however, have in part disputed this conclusion. In
theirreview ofenvironmental hepatic injury, Popper et
al. (42) found only meager evidence of substantiated
chronic hepatic effects. They concluded that conven-
tional liver function tests were of limited value in de-
tecting hepatic abnormalities and that the evidence so
far indicates that too many other processes influence
GGTP activity in man to make it a useful index of in-
duction. The clinical implications ofelevated GGTP lev-
els in man are reviewed by Guzelian elsewhere in this
symposium.
However, the interpretation of the relationship be-
tween serum GGTP and serum lipid PCBs as evidence
ofmicrosomal enzyme induction is strengthened by the
findingofstronginversestatisticalassociationsbetween
both direct and total bilirubin levels and serum lipid
PCBs in 1976 duringthe period ofactive PCB exposure.
Aweakresidual association between serum lipid HPCB
and direct bilirubin (partial r = 0.14) was found in 1979
when the mean total bilirubin (mostly unconjugated)
had risen from 0.46 to 0.61 mg/dL without change in
the mean direct bilirubin (conjugated form) (Table 1).
Since the original observations of Yaffe et al. (43) on
the therapeutic use of phenobarbital to enhance glu-
curonide-conjugating capacity in infant hyperbilirubi-
nemia, a substantial literature has developed linking
drugs (36,44) and other xenobiotics (45,46) to induction
of microsomal enzymes, including enhanced glucuronyl
transferase, resulting in increased conjugation and ac-
celerated hepatic elimination of bilirubin. D-Glucaric acid
is the main excretory product of the glucuronic acid
conjugation pathway and its urinary level also has been
advocated as a measure of enzyme induction (47-50).
Drugs and chemicals inducing microsomal enzymes are
often metabolized by the induced oxidases (32), and it
appears likely that such induction would accelerate
clearance of PCBs as well as bilirubin (49,51).
Hirayama et al. (52) reported serum total bilirubin
levels of0.87 ± 0.33 mg/dL in 257 normal controls and
0.48 ± 0.26 mg/dL in 121 Yusho patients, indicating a
46% decrease in the latter. However, the observations
were made at a time when the PCB levels had declined
to background values, so that the pharmacologically ac-
tive agents present were probably the PCDFs. Induc-
tion ofglucuronyl transferase by Aroclor 1242 and 1016
has been reported in rats (16,53), as has also that of
demethylases (16,53), aniline hydroxylase, (53) and cy-
tochrome P-450 (16,53), but not that of the P-448 cy-
tochrome (16).
Burse et al. (54) have shown that rats fed 100 ppm
of Aroclor 1242 or 1016 (3.9-6.6 and 3.5-6.9 mg/kg!
day) reach equilibrium adipose tissue fat concentrations
of35 to 143 or 69 to 236 ppm, respectively, at 6 months,
levels intherange ofthose observedinthis study(Table
3). Similarlevelsin rats were alsoreported byGoldstein
et al. (53), who found a 3-and 12-fold increase in liver
glucuronyl transferase activity with Aroclors 1016 and
1242, respectively.
Themost compellingevidence formicrosomal enzyme
induction in man is a response to drug administration
(42). In 1977, Alvares et al. (16) reported antipyrene
half-times reduced 31% over matched controls in five
capacitor workers with PCB exposures of4 to 16 years
drawn from the same plant population as the present
study. The effect was statistically significant (p<0.005)
and the half-times were significantly less than the av-
erage values of much larger groups of normal healthy
subjects. The statistical associations ofthe present study,
taken together with the findings of Alvares et al., ap-
pear to indicate induction of the microsomal enzymes
GGTP, glucuronyltransferase, and P-450 oxidase in the
study population during active exposure in 1976. The
enzyme inductions appeared to be smaller than those in
rats carrying similar levels oflipid LPCBs and to have
become virtually undetectable by 1979.
PCB Effects on Hematological Parameters
The findings of significant associations between log
serumlipid PCBs and some hematolotical variables was
unexpected because Maroni et al. (14) reported normal
hematology including WBCs and differentials and no
abnormal reports in occupationally exposed PCB work-
ers have been mentioned by others (11-13,15,17). In
1976 the clinical reports (Table 2) suggested a slight
decline in PMNs with some increases in lymphocytes,
monocytes and eosinophils, and normal values for RBCs,
hemoglobins and hematocrits.
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Interpretations of these data are difficult because of
the shared associations with DDE and the colinearities
with either total or direct bilirubin or both. For the
associations with log total bilirubin, the partial rvalues
were: RBC, +0.19; lymphocytes -0.22; and creatinine,
0.24; for direct bilirubin, they were: phosphate, -0.18;
and creatinine, 0.23. We tend to the interpretation that
these variables are correlated with the enzyme induc-
tion process.
In 1979, although both the monocytes and eosinophils
were only marginally elevated in the study population
based on clinical reports (Tables 1 and 2), the statistical
association ofserum PCB levels and the monocyte counts
was strong.
Because of the absence of a monocytosis in 1976, its
lack of association with either DDE or total or direct
bilirubinin 1979, anditsabsence amongretirees in 1979,
we hypothesized that the effect might be related to a
new exposure in the workplace, perhaps to the PCB-
substitute dielectric. However, we recently studied 54
workers with no prior PCB exposure who were cur-
rently exposed to the substitute and found no monocyte
elevations. Although a number of solvents were in use
in the environment in 1979, the monocytosis was mild
compared to that observed by Minot and Smith (55) in
the case oftetrachlorethane exposure, where the mon-
ocyte levels were elevated 20 to 40%. The effect ofthe
change fromthemanual (1976)toautomateddifferential
analysis (1979) is unknown. We have also hypothesized
that the monocytosis observed in 1979 might be related
to the increased incidence of chronic obstructive lung
disease, heavy smoking or concurrent respiratory in-
fections. We are currently studyingthe associations be-
tween the spirometric variables (FVC, FEV, FEV/
FVC) and the hematological parameters in the study
population and are restudying the entire population,
which should castfurtherlight onany suchrelationships.
Clinical Consequences of PCB Exposure
These findings differ from those ofmost other recent
studies of environmentally or occupationally exposed
populations in offering evidence ofmicrosomal enzyme
induction, which is consistent with the extensive LPCB
clearance also observed in these highly exposed work-
ers. The evidence is statistical in nature and the asso-
ciated parameters remained within their normal clinical
ranges, except possibly forthe lymphocytes in 1976 and
the monocytes in 1979. The effects weretherefore phys-
iological rather than pathological and appeared to sub-
side following the cessation ofPCB use. The long-term
consequencesofsuchenzymeinduction areobscure (42).
The present clinical health of the study population
appears to meet community medical standards. Despite
the prevalence of cardiovascular risk factors (obesity,
elevated cholesterol levels, smoking, etc.) the mortality
experience has been normal. The paucity ofclinical ab-
normalities is consistent with laboratory studies in rats
involving chronic administration of Aroclor 1242 and
1016, producing tissue fat levels comparable to the serum
lipid PCB levels observed here. Such studies (54) have
shown no overt symptoms of clinical poisoning and no
pathological evidence of liver damage. The production
of serious liver damage in rats (56) requires the use of
a largely nonmetabolizable PCB, such as Aroclor 1260,
at a cumulative dose of2.5 g/kg, which would result in
tissue lipid HPCBlevelsabove 10,000ppm, ascompared
to those in our study population of8 ppm in 1976 and 5
to 6 ppm in 1979. It is evident, therefore, why the se-
rioushepaticeffectsinthetestratcouldnotbeobserved
in man.
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